1,444
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood Therapeutics

, , , , , , , , & show all
Pages 1417-1428 | Received 29 Sep 2022, Accepted 31 Oct 2022, Published online: 09 Nov 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.